Drug Shortage Report for RAN-ESOMEPRAZOLE

Last updated on 2020-08-28 History
Report ID 85326
Drug Identification Number 02423979
Brand name RAN-ESOMEPRAZOLE
Common or Proper name RAN-ESOMEPRAZOLE
Company Name RANBAXY PHARMACEUTICALS CANADA INC.
Market Status MARKETED
Active Ingredient(s) ESOMEPRAZOLE
Strength(s) 20MG
Dosage form(s) TABLET (DELAYED-RELEASE)
Route of administration ORAL
Packaging size 100
ATC code A02BC
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-05-28
Estimated end date 2020-12-31
Actual end date
Shortage status Actual shortage
Updated date 2020-08-28
Company comments
Health Canada comments
Contact Address 126 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v32 2020-08-28 French Compare
v31 2020-08-28 English Compare
v30 2020-08-28 English Compare
v29 2020-07-03 French Compare
v28 2020-07-03 English Compare
v27 2020-06-01 French Compare
v26 2020-06-01 English Compare
v25 2020-05-01 French Compare
v24 2020-05-01 English Compare
v23 2020-04-13 French Compare
v22 2020-04-13 English Compare
v21 2020-03-30 French Compare
v20 2020-03-30 English Compare
v19 2020-02-24 French Compare
v18 2020-02-24 English Compare
v17 2020-01-04 French Compare
v16 2020-01-04 English Compare
v15 2019-12-13 French Compare
v14 2019-12-13 English Compare
v13 2019-10-04 French Compare

Showing 1 to 20 of 32